semaglutide california ban update California has ended adult Medi-Cal coverage for popular GLP-1 weight loss medications, leaving thousands of patients worried about losing treatment that helped control diabetes, prevent disease and Novo Nordisk expands Wegovy access

For many people who have struggled with losing weight, semaglutide-based diabetes drugs such as Ozempic and Wegovy have offered a different approach to weight loss

Semaglutide provides a targeted tool to reduce visceral fat and protect your metabolic futurenot by extreme restriction, but by strategically supporting your biology

The process may involve: Consultation with Healthcare Provider : Discussing reasons for switching, reviewing medical history, and assessing suitability for tirzepatide

DietWorks Booster is designed to complement your healthy lifestyle, supporting digestive balance, optimized energy, hydration and overall well-being

Semaglutide is in the GLP-1 receptor agonist class of medications

In a major clinical trial called STEP 8, researchers compared the two medications directly